{
  "actions": [
    {
      "acted_at": "2019-04-11", 
      "action_code": "10000", 
      "references": [], 
      "text": "Introduced in Senate", 
      "type": "action"
    }, 
    {
      "acted_at": "2019-04-11", 
      "action_code": "", 
      "committees": [
        "SSHR"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s1140-116", 
  "bill_type": "s", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Health, Education, Labor, and Pensions", 
      "committee_id": "SSHR"
    }
  ], 
  "congress": "116", 
  "cosponsors": [
    {
      "bioguide_id": "C001075", 
      "district": null, 
      "name": "Cassidy, Bill", 
      "original_cosponsor": true, 
      "sponsored_at": "2019-04-11", 
      "state": "LA", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "C001096", 
      "district": null, 
      "name": "Cramer, Kevin", 
      "original_cosponsor": false, 
      "sponsored_at": "2019-05-07", 
      "state": "ND", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2019-04-11", 
  "number": "1140", 
  "official_title": "A bill to amend the Public Health Service Act with respect to the treatment under section 351(k)(7) of such Act (relating to exclusivity for reference products) of certain products deemed to have a biological product license pursuant to section 7002 of the Biologics Price Competition and Innovation Act of 2009.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "s1895-116", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "hr2011-116", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "Protecting Access to Biosimilars Act of 2019", 
  "sponsor": {
    "bioguide_id": "S001203", 
    "district": null, 
    "name": "Smith, Tina", 
    "state": "MN", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2019-04-11", 
  "subjects": [
    "Allergies", 
    "Blood and blood diseases", 
    "Drug safety, medical device, and laboratory regulation", 
    "Health", 
    "Health promotion and preventive care", 
    "Health technology, devices, supplies", 
    "Immunology and vaccination", 
    "Licensing and registrations"
  ], 
  "subjects_top_term": "Health", 
  "summary": null, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to amend the Public Health Service Act with respect to the treatment under section 351(k)(7) of such Act (relating to exclusivity for reference products) of certain products deemed to have a biological product license pursuant to section 7002 of the Biologics Price Competition and Innovation Act of 2009.", 
      "type": "official"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Protecting Access to Biosimilars Act of 2019", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Protecting Access to Biosimilars Act of 2019", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Protecting Access to Biosimilars Act of 2019", 
      "type": "display"
    }
  ], 
  "updated_at": "2019-07-02T21:53:01Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/s/BILLSTATUS-116s1140.xml"
}